Arena Pharmaceuticals Inc News

Arena Pharmaceuticals Inc News From AOL News

FDA Panel Rejects Experimental Weight Loss Pill

GAITHERSBURG, MD. (July 15) -- A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug's side effects outweigh its ability to help patients lose weight. The Food and Drug Administration panel voted 10-6 against Vivus's Qnexa, citing...

Arena Pharmaceuticals Inc News From AOL

THE HUFFINGTON POST

Heart Risks Of Obesity Drugs: U.S. Ponders Safety Trials Before Approval

U.S. health regulators are asking for advice on whether, and when, heart safety studies should be required for new obesity drugs, possibly adding a new hurdle on their path to approval.

Arena Pharmaceuticals Inc News From the Web

05/25/12 Stocks with implied volatility below IV index mean;... Source: Theflyonthewall.com
05/24/12 Perception, Opportunity in Volatility - Research &... Source: Marketwire HONG KONG -- (Marketwire) -- 05/24/12 -- This morning, www.MarketFoundations.com announced new reports highlighting Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and DryShips Inc. (NASDAQ: DRYS).
05/23/12 Equity Research on Most Popular Searches: Arch Coal,... Source: PR Newswire VANCOUVER, British Columbia , May 23, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Arch Coal (NYSE:ACI), El Paso (NYSE:EP), Cree (NASDAQ:CREE), Barrick Gold (NYSE:ABX), Arena Pharmaceuticals (NASDAQ:ARNA), and CSX (NYSE:CSX).
05/22/12 Institutional Investors Bet On Prolor, Synergy, Arena... Source: Seeking Alpha Teva Pharmaceutical Industries ( TEVA ) Chairman Dr. Phillip Frost bought $5 Million worth of Prolor Biotech ( PBTH ) stock, according to a filing with the SEC last week.
05/22/12 Arena Pharmaceuticals moves up in early trading,... Source: Theflyonthewall.com